CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 235.5 SEK -1.46%
Market Cap: 5.6B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

CellaVision AB
Capital Expenditures Peer Comparison

Comparables:
EKTA B
S
SUS
GETI B
ARJO B
S
STIL

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Capital Expenditures
-kr78.2m
CAGR 3-Years
-23%
CAGR 5-Years
-32%
CAGR 10-Years
-17%
Elekta AB (publ)
STO:EKTA B
Capital Expenditures
-kr1.6B
CAGR 3-Years
-25%
CAGR 5-Years
-20%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Capital Expenditures
-kr50.7m
CAGR 3-Years
-78%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Capital Expenditures
-kr1.4B
CAGR 3-Years
-9%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Capital Expenditures
-kr403m
CAGR 3-Years
21%
CAGR 5-Years
9%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Capital Expenditures
-kr13.4m
CAGR 3-Years
14%
CAGR 5-Years
-29%
CAGR 10-Years
-22%

See Also

What is CellaVision AB's Capital Expenditures?
Capital Expenditures
-78.2m SEK

Based on the financial report for Jun 30, 2024, CellaVision AB's Capital Expenditures amounts to -78.2m SEK.

What is CellaVision AB's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-17%

Over the last year, the Capital Expenditures growth was 5%. The average annual Capital Expenditures growth rates for CellaVision AB have been -23% over the past three years , -32% over the past five years , and -17% over the past ten years .

Back to Top